Skip to main content
Log in

Levonorgestrel — Implant

Jadelle®, Norplant-2®

  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I
Table II

Notes

  1. This profile has been selected from R&D Insight™, a pharmaceutical intelligence database produced by Adis International Ltd.

References

  1. Sivin I, Wan L, Ranta S, Alvarez F, Brache V, et al. Levonorgestrel concentrations during 7 years of continuous use of Jadelle contraceptive implants. Contraception 64: 43–49, Jul 2001

    Article  PubMed  CAS  Google Scholar 

  2. Sivin I, Alvarez F, Mishell Jr DR, Darney P, Wan L, et al. Contraception with two levonorgestrel rod implants: a 5-year study in the United States and Dominican Republic. Contraception 58: 275–282, Nov 1998

    Article  PubMed  CAS  Google Scholar 

  3. Mascarenhas L, van Beek A, Bennink HC, Newton J. Twentyfour month comparison of apolipoproteins A-1, A-II, and B in contraceptive implant users (Norplant (Rm) and Implanon (Rm)) in Birmingham, United Kingdom. Contraception 58: 215–219, Oct 1998

    Article  PubMed  CAS  Google Scholar 

  4. Chompootaweep S, Kochagarn E, Tang-Usaha J, Theppitaksak B, Dusitsin N. Experience of Thai women in Bangkok with Norplant-2 (Rm) implants. Contraception 58: 221–225, Oct 1998

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Levonorgestrel — Implant. Drugs in R&D 3, 398–400 (2002). https://doi.org/10.2165/00126839-200203060-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-200203060-00006

Keywords

Navigation